Episode
Naveed Sattar on early, large-scale weight loss & the future of type 2 diabetes care, Laurent Azoulay on GLP-1s & the risk for optic neuropathy, plus a classic edition of "Rapid Exchange."
- Podcast
- Diabetes Care "On Air"
- Published
- May 4, 2026
- Duration seconds
- 3007
- Processing state
not_requested- Canonical source
- https://diabetescareonair.libsyn.com/site
Actions
POST https://stenobird.com/v1/public/podcasts/diabetes-care-on-air-5983699/episodes/naveed-sattar-on-early-large-scale-weight-loss-the-future-of-type-2-diabetes-care-laurent-azoulay-on-glp-1s-the-risk-for-optic-neuropathy-plus-a-classic-edition-of-rapid-exchange/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/diabetes-care-on-air-5983699/naveed-sattar-on-early-large-scale-weight-loss-the-future-of-type-2-diabetes-care-laurent-azoulay-on-glp-1s-the-risk-for-optic-neuropathy-plus-a-classic-edition-of-rapid-exchange.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome to the latest episode (May 2026) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the May 2026 issue of Diabetes Care and beyond. 4:45 Alice welcomes Naveed Sattar , MBChB, PhD, Professor of Cardiometabolic Medicine at the University of Glasgow. He is a co-author on the article "Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care," available for free at doi.org/10.2337/dci25-0069 . 30:05 Mike speaks with Laurent Azoulay , PhD, Associate Professor in the Department of Epidemiology, Biostatistics and Occupational Health and Gerald Bronfman Department of Oncology, McGill University in Montreal, Canada. He is senior author on the article "Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes," available for free at doi.org/10.2337/dc25-2577 . 36:15 In this month's "Rapid Exchange" segment, Alice and Mike wrap up the episode by reviewing several interesting articles in the May 2025 issue of Diabetes Care. Studies highlighted in this segment include: Ganeshalingam et al. Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly doi.org/10.2337/dc25-2041 Mital et al. Everyone or Just Some? Cost-Effectiveness of General Population Versus Targeted Screening Strategies for Type 1 Diabetes in Canada doi.org/10.2337/dc25-2248 Weiskorn et al. Hypercholesterolemia and Lipid-Lowering…